产品名称 | Abemaciclib (LY2835219) |
---|---|
英文名称 | Abemaciclib (LY2835219) |
别名 | LY2835219;LY 2835219;LY-2835219 |
英文别名 | CDK4/6 dual inhibitor;LY 2835219;LY-2835219;N-[5-[(4-Ethyl-1-piperazinyl)methyl]-2-pyridinyl]-5-fluoro-4-[4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl]-2-pyrimidinamine methanesulfonate (1:1) |
规格或纯度 | ≥98% |
运输条件 | 超低温冰袋运输 |
生化机理 | LY2835219 is an orally available cyclin-dependent kinase (CDK) inhibitor that targets the CDK4 (cyclin D1) and CDK6 (cyclin D3) cell cycle pathway, with potential antineoplastic activity. CDK4/6 dual inhibitor LY2835219 specifically inhibits CDK4 and 6, thereby inhibiting retinoblastoma (Rb) protein phosphorylation in early G1. Inhibition of Rb phosphorylation prevents CDK-mediated G1-S phase transition, thereby arresting the cell cycle in the G1 phase, suppressing DNA synthesis and inhibiting cancer cell growth. Overexpression of the serine/threonine kinases CDK4/6, as seen in certain types of cancer, causes cell cycle deregulation. |
LY2835219对CDK4和CDK6的IC50分别为2 nM和10 nM。
LY2835219 is a potent and selective inhibitor of CDK4 and CDK6 with IC50 of 2 nM and 10 nM in cell-free assays, respectively.
CAS编号 | 1231930-82-7 |
---|---|
溶解性 | DMSO 83 mg/mL Water 100 mg/mL Ethanol 24 mg/mL |
储存温度 | -20°C储存 |
分子量 | 602.7 |
分子式 | C27H32F2N8.CH4O3S |
品牌 | 阿拉丁 |
PubChem CID | 71576678 |